AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2023
May 3, 2023
284_dirs_2023-05-03_9b7cf3f4-80ef-47ed-9443-a23d88066d40.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2023-05-01
Reporting Person: Karachun Rita A (Sr. VP Fince-Global Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-01 | Common Stock | M | 930 | $115.47 | Acquired | 44878.972 | Direct |
| 2023-05-01 | Common Stock | F | 319 | $115.47 | Disposed | 44559.972 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-01 | Restricted Stock Unit | $ | M | 930 | Disposed | 2023-05-01 | Common Stock (930) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8